AMGN Earnings
Latest Revenue10.1B
Latest Net Income2.4B
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $4.40 | 10.1B | 2.4B | +9.5% | +65.4% |
| Q1 2026 | $3.37 | 8.6B | 1.8B | +5.8% | +4.7% |
| Q4 2025 | $2.48 | 9.9B | 1.3B | +8.6% | +112.0% |
| Q3 2025 | $5.98 | 9.6B | 3.2B | +12.4% | +13.5% |
| Q2 2025 | $2.66 | 9.2B | 1.4B | +9.4% | +91.4% |
| Q1 2025 | $3.22 | 8.1B | 1.7B | +9.4% | +1,633.3% |
| Q4 2024 | $1.17 | 9.1B | 627.0M | +10.9% | -18.2% |
| Q3 2024 | $5.27 | 8.5B | 2.8B | +23.2% | +63.2% |
| Q2 2024 | $1.39 | 8.4B | 746.0M | — | — |
| Q1 2024 | -$0.21 | 7.4B | -113000000 | — | — |
| Q4 2023 | $1.43 | 8.2B | 767.0M | — | — |
| Q3 2023 | $3.23 | 6.9B | 1.7B | — | — |
Amgen (AMGN) — Earnings